Piper Sandler lowered the firm’s price target on Axon (AXON) to $674 from $690 and keeps an Overweight rating on the shares. The firm recognizes that Q1s tend to be less of a “showy” quarter for Axon just given seasonality. However, the team executed well, introduced multiple new products recently at the user-conference, and showed very solid bookings upside, Piper highlights. The firm adds that Axon remains its top-pick.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- Why Is Invesco QQQ Trust ETF (QQQ) Inching Higher, 5/7/2026?
- Axon price target lowered to $700 from $825 at Citizens
- Axon Maintained at Buy as Strong Growth Outlook Supports Unchanged $600 Price Target
- Axon Enterprise options imply 12.5% move in share price post-earnings
- Axon reports Q1 EPS $1.61, consensus $1.60